A Study to Compare the Efficacy and Safety of Ustekinumab to that of Adalimumab in
the Treatment of Subjects with Active Crohn’s Disease
How does treatment with Ustekinumab compare to treatment with Adalimumab in patients
with active Crohn's Disease?
Basic Study Information
Purpose:Study Web URL: https://clinicaltrials.gov/ct2/show/NCT03464136?term=seavue&rank=1
The purpose of this study is to compare the effectiveness of the drug Ustekinumab
to the drug Adalimumab in patients who have moderate to severe Crohn's disease. The
study will test Ustekinumab compared to Adalimumab for 56 weeks. To determine if the
effectiveness of each drug, patients will come to the clinic regularly to meet with
the study team, complete questionnaires, and have blood work completed.
Study Reference #: 71830
Lead Researcher (Principal Investigator)
Lead Researcher: Lawrence Saubermann
Study Contact InformationStudy Coordinator: Cindy Doane
Phone: (585) 276-6019
Additional Study Details
Learn More About These Conditions
More information about Crohn Disease
Trial Not Found
The study you are looking for is not active at this time.
Return to Search